Related content

HIGH-RISK NEUROBLASTOMA: A Therapy in Evolution

By Fong Abraham   Park Julie R.  

Pediatric Hematology and Oncology, Vol. 26, Iss. 8, 2009-11 ,pp. : 539-548

Informa Healthcare

Access to resources Recommend Favorite

Brown adipose tissue F-FDG uptake in pediatric PET/CT imaging

By Hong Terence   Shammas Amer   Charron Martin   Zukotynski Katherine   Drubach Laura   Lim Ruth  

Pediatric Radiology, Vol. 41, Iss. 6, 2011-06 ,pp. : 759-768

Springer Publishing Company

Access to resources Recommend Favorite

A CASE SERIES OF CHILDREN WITH HIGH-RISK METASTATIC NEUROBLASTOMA TREATED WITH A NOVEL TREATMENT STRATEGY CONSISTING OF POSTPONED PRIMARY SURGERY UNTIL THE END OF SYSTEMIC CHEMOTHERAPY INCLUDING HIGH-DOSE CHEMOTHERAPY

By Hashii Yoshiko   Kusafuka Takeshi   Ohta Hideaki   Yoneda Akihiro   Osugi Yuko   Kobayashi Yasutsugu   Fukuzawa Masahiro   Hara Junichi  

Pediatric Hematology and Oncology, Vol. 25, Iss. 5, 2008-06 ,pp. : 439-450

Informa Healthcare

Access to resources Recommend Favorite

LONG-TERM RESULTS OF HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS STEM CELL RESCUE FOR HIGH-RISK NEUROBLASTOMA PATIENTS: A Report of the Spanish Working Party for BMT in Children (GETMON)

By Verdeguer A.   Muñoz A.   Cañete A.   Pardo N.   Martínez A.   Donat J.   Gómez P.   Bureo E.   Fernández J.   Cubells J.   Maldonado M.   Sastre A.  

Pediatric Hematology and Oncology, Vol. 21, Iss. 6, 2004-09 ,pp. : 495-502

Informa Healthcare

Access to resources Recommend Favorite

Relapse in the Skull After Myeloablative Therapy for High-Risk Neuroblastoma

By Sangthawan D.   DesRosiers P. M.   Randall M. E.   Robertson K.   Goebel S.   Fallon R.  

Pediatric Hematology and Oncology, Vol. 20, Iss. 1, 2003-01 ,pp. : 23-30

Informa Healthcare

Access to resources Recommend Favorite